title: Quality of life study following cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei including redo procedures.
abstract: BACKGROUND
  Our aim was to evaluate the quality of life following cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei. We also conducted an analysis of all patients who underwent CRS and HIPEC for pseudomyxoma peritonei from 1997 to 2012.
  
  
  METHODS
  We contacted 87 patients using the FACT C (version 4) quality of life questionnaire, and FACIT-TS-G (version 1) was also used.
  
  
  RESULTS
  A total of 63 patients (response rate 72%) were available for quality of life interview and analysis. The median time from surgery to questionnaire evaluation was 31 months (range 6-161 months). 62% were females with an average age of 54 years. 22% of the patients had over one cytoreductive surgical procedure. We analysed our patients postoperatively based on physical, functional, social, and emotional well being who reported favourable outcomes in all sections. Patients who had a single procedure had a significantly higher score (P = 0.016) in the additional concerns section of the questionnaire. The patients who had a single procedure had better gastrointestinal digestion in terms of bowel control, appetite, and food digestion and also body appearance scoring.
  
  
  CONCLUSIONS
  79% of the patients stated that they would undergo further cytoreductive surgery and that redo procedures do not result in a significantly worse quality of life.
authors: Hepatobiliary and Surgical Oncology Unit, UNSW Department of Surgery, St. George Hospital, Sydney, NSW 2217, Australia.
authors: Rachel
authors: R
authors: Kirby
authors: Winston
authors: W
authors: Liauw
authors: Jing
authors: J
authors: Zhao
authors: David
authors: D
authors: Morris
mesh_terms: D003131:Combined Modality Therapy / Q000379:methods; D005260:Female; D006358:Hot Temperature / Q000627:therapeutic use; D006801:Humans; D006979:Hyperthermia, Induced; D008297:Male; D008875:Middle Aged; D010534:Peritoneal Neoplasms / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D011553:Pseudomyxoma Peritonei / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D011788:Quality of Life; D012307:Risk Factors; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
references: World J Surg. 2010 Jan;34(1):62-9
references: 20020294
references: Ann Surg. 2009 Jun;249(6):900-7
references: 19474692
references: Ann Surg. 2007 Jan;245(1):104-9
references: 17197972
references: Eur J Surg Oncol. 2009 Feb;35(2):202-8
references: 18514475
references: Dis Colon Rectum. 2008 Jun;51(6):868-74
references: 18297361
references: In Vivo. 2009 Jul-Aug;23(4):639-44
references: 19567401
references: Eur J Surg Oncol. 2001 Feb;27(1):65-73
references: 11237495
references: Int J Surg Oncol. 2011;2011:468698
references: 22312509
references: Ann Surg Oncol. 2006 Dec;13(12):1627-32
references: 17013686
references: Ann Surg Oncol. 2011 Dec;18(13):3673-9
references: 21674272
references: Eur J Surg Oncol. 2005 Feb;31(1):53-8
references: 15642426
references: World J Gastrointest Oncol. 2010 Jan 15;2(1):44-50
references: 21160816
references: Ann Surg Oncol. 2003 Oct;10(8):863-9
references: 14527903
references: Eur J Surg Oncol. 2010 Dec;36(12):1156-61
references: 20864306
references: Cancer. 2006 Mar 1;106(5):1144-53
references: 16456817
references: Int J Colorectal Dis. 2005 Mar;20(2):155-60
references: 15503065
references: Ann Surg Oncol. 2007 Feb;14(2):484-92
references: 17054002
references: Lancet Oncol. 2006 Jan;7(1):69-76
references: 16389186
references: Mod Pathol. 2001 Mar;14(3):164-71
references: 11266521
references: Ann Surg Oncol. 2003 Mar;10(2):155-62
references: 12620911
references: Dis Colon Rectum. 2011 Mar;54(3):293-9
references: 21304299
references: Ann Surg. 1995 Jan;221(1):29-42
references: 7826158
references: Health Technol Assess. 2004 Feb;8(7):iii, 1-54
references: 14960255
references: Ann Surg Oncol. 2008 Mar;15(3):745-53
references: 18057988
references: Eur J Surg Oncol. 2001 Apr;27(3):239-43
references: 11373099
references: J Surg Oncol. 2008 Sep 15;98(4):277-82
references: 18726894
references: J Surg Oncol. 2009 Sep 15;100(4):317-20
references: 19697438
references: Ann Surg Oncol. 2004 Apr;11(4):393-8
references: 15070599